Delivery Order SPE2DB20D1051-SPE2DB25FD9BB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,375.76. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,787.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,131.33 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This non-competitive delivery order, issued on September 19, 2025, represents a firm fixed price purchase with an ultimate completion date of September 22, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.32 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 22, 2025, with completion expected by September 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The delivery order will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,163.54 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed price contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a non-set-aside, competitive basis and will be performed at...
- The Defense Logistics Agency (DLA) awarded a $16,248.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 6, 2025, with an ultimate completion date of August 7, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed-price contract, awarded on August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,051.18 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexcom G7 sensors, continuous glucose monitoring devices used for diabetes management. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9BBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,031.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order likely falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026, which serves as the primary pharmaceutical procurement vehicle for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing comprehensive medical supplies and medications to federal healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated consistent capability to compete for and fulfill federal medical procurement requirements through open competition. The Dexcom G7 sensors being delivered under this order are continuous glucose monitoring devices used for diabetes management within military healthcare systems. This award reflects AmerisourceBergen's established role as a critical vendor supporting the DLA's Medical Supply Chain and its participation in the broader federal pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/13/25 |